Aclaris Therapeutics, Inc. (ACRS) — Dilution Risk Analysis
Current Snapshot
Aclaris Therapeutics, Inc. (ACRS) has a DilutionWatch score of 65/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 65/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 8, 8-K 2.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-04-27 | 0001373604-26-000034 |
| 8-K | 2026-03-11 | 0001104659-26-026407 |
| 8-K | 2026-03-10 | 0001104659-26-025420 |
| 4 | 2026-03-03 | 0001957554-26-000011 |
| 4 | 2026-02-06 | 0001957554-26-000009 |
| 4 | 2026-02-06 | 0001781549-26-000013 |
| 4 | 2026-02-06 | 0002065269-26-000002 |
| 4 | 2026-02-06 | 0002076327-26-000002 |
| 4 | 2026-02-06 | 0002045027-26-000004 |
| 4 | 2026-02-06 | 0001604457-26-000007 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 2 months | Source |
| Three-year share count growth | 107.8% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 65/10) Source
- Cash Runway
- 2 months Source
- Share Count Growth (3-Year)
- 107.8% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.